intron 9 of the CD44 gene. The transcription of these CD44 components was also examined by RT-PCR of snap-frozen solid tissue specimens from 11 ofthe above patients with colorectal carcinoma, seven with ulcerative colitis and five with Crohn's disease. Results-Abnormal expression of exons l1(v6) and 12(v7) was detected in exfoliated cells from 11 (73%) of 15 patients with carcinoma, but not in any patients with inflammatory bowel disease (IBD). The retention of intron 9 in CD44 mRNA transcripts was detected in washings from four (27%) carcinoma specimens but not in washings from non-malignant specimens.
It was confirmed that in solid tissue samples from the same carcinomas there was abnormal over-expression of numerous alternatively spliced CD44 species containing transcripts of exons 11 and 12 and retention of intron 9. Low level expression of these exons was detected in tissue from inflammatory lesions from five of seven patients with ulcerative colitis and four of five with Crohn's disease. The retention ofintron 9 was not seen in normal mucosa nor IBD. Colorectal carcinoma is one of the most common fatal neoplasms in many countries. Surgical treatment is very effective if the tumour is removed before it has spread but, despite recent advances in the clinical investigation of bowel disorders, including double contrast barium enema and endoscopy, the early detection of colorectal carcinoma is still a major clinical problem. The colorectal cancer. In preliminary experiments we have successfully detected abnormal CD44 expression using RT-PCR on mRNA from exThis is foliated cells in stools from a small group of results of patients (six of 11) with colorectal cancer, but ilter with not in ones from normal subjects (Matsumura ough the and Tarin, unpublished observations). Howafter hy-ever, for the sensitivity and specificity of this n 9 probe approach to be evaluated accurately, it will be ripts con-necessary to develop reliable techniques for ;ults show retrieving viable exfoliated cells from evacuated the RNA stools. Clinical bowel preparation regimens cases 51 which render the stools liquid and evacuate the obtained lumen in preparation for surgery or radiological ated with and endoscopic examination may be helpful ns 11 and for this purpose.
Conclusion-Abnormal
The proportion of patients with colorectal nation re-cancer in whom we have identified disturbances ieir faecal in CD44 gene expression in the colonic luminal of cyto-contents, and thus inferred the presence of ated cells exfoliated cancer cells, compares favourably n table 1. with figures published in previous reports, using itive with other molecular markers. For example, p53 f whether gene mutations were detected in 1-7% of exAlso, the foliated cells in the urine of three patients with exfoliated bladder cancer,'6 whilst H-ras gene mutations t because were observed in the urinary cells of 10 The results obtained in the current study and in others described above further indicate that tests for this and/or other genetic abnormalities will probably soon revolutionise the diagnostic repertoire for this condition. Traditional methods for non-invasive investigation or screening for bowel cancer are extremely crude. Testing for faecal occult blood is unsatisfactory as a detection method for colorectal carcinomas as demonstrated in table 1. Most of the patients with carcinoma in the present study had symptoms of anal bleeding or tested positive for faecal occult blood. However, most of the patients with IBD also had the same symptoms, illustrating the difficulty of discriminating between patients with cancer and those with IBD. Cytology is a powerful and reliable method for identifying cancer cells, but it is labour intensive, expensive and depends heavily on the quality of preservation of the cells in the sample. It has not been found to be useful for the diagnosis of colorectal cancer, as demonstrated above. The data now accumulating indicate that molecular genetic analytical methods are poised to offer more specific and informative diagnostic alternatives.
Although this work has shown that the level and pattern of expression of exons 11 and 12 of the CD44 gene were deranged in tumour tissues compared with IBD lesions, it is important to note that orderly, low level expression of these exons similar to that seen in extracts of normal tissues was detectable in the samples from the non-neoplastic diseases ( fig  2) . Rosenberg et al27 have reported recently that raised expression of CD44 variant exon 3 (exon 8) and variant exon 6 (exon 11) encoded epitopes was detected immunohistochemically on colonic crypt epithelial cells in 23 of 25 ulcerative colitis samples compared with three of 18 samples of colonic Crohn's disease. The data presented here show that using RT-PCR, it is easy to distinguish between the normal, inflammatory and neoplastic patterns of expression of the variable region of this gene, both in tissues and in exfoliated cells.
The over-abundant transcripts produced by the CD44 gene in tumour cells contain immature or defective mRNA species of a wide range of sizes, with retained intronic sequences.'415 This additional distinguishing feature was confirmed in all the tumour tissues examined in this study, which has verified that intron retaining transcripts are not detected in IBD lesions. This abnormality might be a highly specific marker of neoplasia, but its sensitivity was low (27%) in our studies on colonic washings. We consider that this result might be attributable to the relatively low proportion of such immature transcripts in the cellular mRNA pool and the lower numbers of cancer cells in the washings than in tissue specimens.
This present study indicates that the molecular analysis of colon luminal washings could be a useful adjunct to endoscopy in establishing a diagnosis of colorectal cancer. In order to evaluate this, we are now conducting studies on cells washed from the colon during bowel preparations prior to radiological examination or surgery. In some cases it is difficult to examine the entire lumen of the colon and in others there is uncertainty about whether a stricture results from carcinoma, IBD or diverticulitis; examination of exfoliated cells in luminal washings might help make a diagnosis.
In conclusion, the main significance of the observations in this study is that they demonstrate the feasibility of detecting abnormal gene activity in exfoliated colorectal cancer cells and suggest that it may be possible to diagnose the condition successfully by conducting similar tests on evacuated stools.
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